help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Meirhaeghe, A.
Right arrow Articles by Wareham, N. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Meirhaeghe, A.
Right arrow Articles by Wareham, N. J.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*OMIM
*UniGene
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*GLUCOSE
The Journal of Clinical Endocrinology & Metabolism Vol. 86, No. 12 5881-5887
Copyright © 2001 by The Endocrine Society


Other Original Articles

The Effect of the Gly16Arg Polymorphism of the ß2-Adrenergic Receptor Gene on Plasma Free Fatty Acid Levels Is Modulated by Physical Activity

Aline Meirhaeghe, Jian’an Luan, Paul Selberg-Franks, Susie Hennings, Jo Mitchell, David Halsall, Stephen O’Rahilly and Nicholas J. Wareham

Departments of Medicine (A.M., S.O.), Clinical Biochemistry (A.M., D.H., S.O.), and Public Health and Primary Care (J.L., P.S.-F., S.H., J.M., N.J.W.), University of Cambridge, Cambridge CB2 2SR, United Kingdom

Address all correspondence and requests for reprints to: Dr. Nicholas J. Wareham, Institute of Public Health, University of Cambridge, Robinson Way, Cambridge CB2 2SR, United Kingdom.

Abstract

The lipolytic effects of catecholamines are mediated through members of the ß2-adrenergic receptor (BAR-2) family. Previous studies have suggested that genetic variants in the BAR-2 gene may be associated with obesity in some populations. To our knowledge, no studies have directly examined the effects of this polymorphism on circulating nonesterified fatty acid (NEFA) levels. To explore this issue further, a cohort of 604 Caucasian individuals (aged 40–65 yr) was genotyped for a common polymorphism in the BAR-2 gene (Gly16Arg), and the relationships between genotype, body mass index (BMI), NEFA, and lipid levels were examined. Women bearing the Arg16 allele had higher BMI values (P < 0.01) than Gly16Gly women. Women carriers of the Arg16Arg genotype had lower fasting plasma NEFAs (P < 0.01) and greater suppression of NEFAs (P < 0.01) after an oral glucose load than women bearing the Gly16 allele. In multivariate analysis after adjustment for age, sex, and smoking status, the interaction between the BAR-2 genotype and BMI in determining fasting NEFA concentrations was statistically significant (P < 0.05). The availability of objective measures of total energy expenditure in this population permitted the further examination of interactions, particularly that between genotype and physical activity. In the population as a whole, after adjustment for confounding by age, smoking, and BMI, the effect of the Arg16Arg genotype on the suppression of NEFA levels was modified by physical activity level (P for interaction <0.05). These data suggest the existence in this population of a gene-physical activity interaction on NEFA levels.




This article has been cited by other articles:


Home page
HypertensionHome page
M. Tomaszewski, F. J. Charchar, B. Lacka, U. Pesonen, W. Y.S. Wang, E. Zukowska-Szczechowska, W. Grzeszczak, and A. F. Dominiczak
Epistatic Interaction Between {beta}2-Adrenergic Receptor and Neuropeptide Y Genes Influences LDL-Cholesterol in Hypertension
Hypertension, November 1, 2004; 44(5): 689 - 694.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. Dallongeville, N. Helbecque, D. Cottel, P. Amouyel, and A. Meirhaeghe
The Gly16->Arg16 and Gln27->Glu27 Polymorphisms of {beta}2-Adrenergic Receptor Are Associated with Metabolic Syndrome in Men
J. Clin. Endocrinol. Metab., October 1, 2003; 88(10): 4862 - 4866.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
A. C. Pereira, M. S. Floriano, G. F.A. Mota, R. S. Cunha, F. L. Herkenhoff, J. G. Mill, and J. E. Krieger
{beta}2 Adrenoceptor Functional Gene Variants, Obesity, and Blood Pressure Level Interactions in the General Population
Hypertension, October 1, 2003; 42(4): 685 - 692.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
J. A. Martinez, M. S. Corbalan, A. Sanchez-Villegas, L. Forga, A. Marti, and M. A. Martinez-Gonzalez
Obesity Risk Is Associated with Carbohydrate Intake in Women Carrying the Gln27Glu {beta}2-Adrenoceptor Polymorphism
J. Nutr., August 1, 2003; 133(8): 2549 - 2554.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2001 by The Endocrine Society